Opinion: Who deserves the blame for medical device OEM restructuring?


The New York Times Editorial Board has weighed in strongly in favor of the 2.3% excise tax included in the 2010 Affordable Care Act, often referred to as "Obamacare". The New York Times also criticized the medical device industry for its multi-million-dollar attacks on the tax as well as many U.S. Senators for not bucking industry lobbying.

"The industry claims the tax will hurt demand for its products, but, in fact, sales of these devices, which are not purchased directly by consumers, are unlikely to be affected by price, especially by a small tax increase," states the Times editorial. "As more people receive health coverage that pays for devices, the industry will more than make up the cost of the tax."

The Times editorial, while largely correct, does not address the unfortunate timing of the tax. It comes during a time of enforced cost-cutting and demand still lagging from the effects of the recession of 2008-2009....
Read more